In the context of Chronic Lymphocytic Leukemia (CLL), "CD38" is considered a key prognostic marker, often associated with plasma cells, indicating a poorer prognosis when expressed at high levels on the surface of leukemia cells; meaning that high CD38 expression on CLL cells suggests a more aggressive disease progression and potentially shorter survival time for the patient.